高级检索

基于快速组装策略的FAK降解剂的设计、合成及生物活性评价

Design, Synthesis and Biological Evaluation of FAK Degraders Based on a Rapid Assembly Strategy

  • 摘要: 为快速发掘高活性黏着斑激酶(Focal adhesion kinase,FAK)靶向蛋白降解剂,缩短 PROTAC 分子合成与活性筛选周期,本文采用模块化快速组装策略,高效并行构建 FM2-A、FM2-B 两大系列共 12 个全新 FAK 降解分子。以 DMSO 为空白对照、已知 FAK 降解分子为阳性对照,通过蛋白质免疫印迹(Western blot)技术在细胞水平系统评价所有化合物的 FAK 蛋白降解活性。结果显示,FM2-A1~A3、FM2-B1~B3 在 0.1、1 μM 浓度下无明显靶标降解能力;FM2-A4~A6、FM2-B4~B6 呈现浓度依赖性 FAK 降解效应,其中 FM2-A6 降解活性最优,1 μM 作用下靶蛋白降解效率显著优于同系列其余衍生物,但弱于阳性对照分子。构效分析表明,连接链与弹头配体的模块化快速组合可快速调控降解分子的细胞内靶标清除能力。本研究建立的模块化快速组装、同步活性筛选一体化体系,大幅提升 FAK 降解先导化合物的发现效率,为快速开发其他激酶靶点 PROTAC 降解剂提供高效合成与筛选研究基础。

     

    Abstract: To rapidly discover potent focal adhesion kinase (FAK)-targeted protein degraders and shorten the cycles of PROTAC synthesis and activity screening, a modular rapid assembly strategy was adopted in this work to efficiently construct two series (FM2-A and FM2-B) containing a total of 12 novel FAK degrader molecules in parallel. With DMSO set as the blank control and a known FAK degrader as the positive control, Western blot was utilized to systematically evaluate the FAK protein degradation activity of all compounds at the cellular level. The results revealed that FM2-A1–A3 and FM2-B1–B3 exhibited negligible target degradation capacity at 0.1 μM and 1 μM; FM2-A4–A6 and FM2-B4–B6 exerted concentration-dependent FAK degradation effects, among which FM2-A6 possessed the optimal degradation activity. At 1 μM, FM2-A6 displayed markedly higher target protein degradation efficiency than other derivatives in the same series, while its activity was inferior to that of the positive control. Structure activity relationship analysis demonstrated that rapid modular combination of linkers and warheads enables flexible regulation of the intracellular target clearance capacity of degraders. The integrated system combining modular rapid assembly and simultaneous activity screening established herein greatly improves the discovery efficiency of lead FAK degraders, and lays an efficient synthetic and screening foundation for the rapid development of PROTAC degraders targeting other kinase targets.

     

/

返回文章
返回